HK1210476A1 - A method of weak partitioning chromatography - Google Patents

A method of weak partitioning chromatography

Info

Publication number
HK1210476A1
HK1210476A1 HK15111155.1A HK15111155A HK1210476A1 HK 1210476 A1 HK1210476 A1 HK 1210476A1 HK 15111155 A HK15111155 A HK 15111155A HK 1210476 A1 HK1210476 A1 HK 1210476A1
Authority
HK
Hong Kong
Prior art keywords
weak partitioning
partitioning chromatography
chromatography
weak
partitioning
Prior art date
Application number
HK15111155.1A
Other languages
English (en)
Chinese (zh)
Inventor
Paul Brown
Jon Coffman
Ranganathan Godavarti
Tim Iskra
Brian D Kelley
Suresh Vunnum
Shujun Sun
Tianning Yu
James Edward Booth
Mary Beth Switzer
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36992346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210476(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1210476A1 publication Critical patent/HK1210476A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30—Partition chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
HK15111155.1A 2005-03-11 2015-11-12 A method of weak partitioning chromatography HK1210476A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66043705P 2005-03-11 2005-03-11

Publications (1)

Publication Number Publication Date
HK1210476A1 true HK1210476A1 (en) 2016-04-22

Family

ID=36992346

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111155.1A HK1210476A1 (en) 2005-03-11 2015-11-12 A method of weak partitioning chromatography

Country Status (21)

Country Link
US (3) US8067182B2 (fr)
EP (1) EP1869065B1 (fr)
JP (1) JP5199063B2 (fr)
KR (2) KR101660575B1 (fr)
CN (2) CN104610422A (fr)
AU (1) AU2006223180B2 (fr)
BR (1) BRPI0608584B8 (fr)
CA (1) CA2601062C (fr)
CR (1) CR9377A (fr)
DK (1) DK1869065T3 (fr)
ES (1) ES2797480T3 (fr)
HK (1) HK1210476A1 (fr)
HU (1) HUE049797T2 (fr)
IL (1) IL185687A (fr)
MX (1) MX2007011129A (fr)
NO (1) NO20074443L (fr)
PL (1) PL1869065T3 (fr)
PT (1) PT1869065T (fr)
RU (1) RU2457214C2 (fr)
SI (1) SI1869065T1 (fr)
WO (1) WO2006099308A2 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling
JP2010510963A (ja) * 2006-06-14 2010-04-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー セラミックヒドロキシアパタイトを使用する抗体の精製方法
US8513393B2 (en) 2006-08-28 2013-08-20 Ares Trading S.A. Process for the purification of Fc-containing proteins
WO2008031020A2 (fr) * 2006-09-08 2008-03-13 Wyeth Solution de lavage contenant de l'arginine utilisée dans la purification de protéines par chromatographie d'affinité
SG10201510384UA (en) 2006-09-13 2016-01-28 Abbvie Inc Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
KR101523782B1 (ko) 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지
HUE037409T2 (hu) * 2007-10-30 2018-08-28 Genentech Inc Antitest-tisztítás kationcserés kromatográfiával
EP2238154B1 (fr) 2008-01-18 2015-09-16 Bio-Rad Laboratories, Inc. Purification améliorée de biomolécules phosphorylées et non phosphorylées par chromatographie sur hydroxyapatite
WO2010019148A1 (fr) † 2008-08-14 2010-02-18 Genentech, Inc. Procédés d'élimination d'un contaminant au moyen de la chromatographie à membrane échangeuse d'ions avec déplacement de protéines indigènes
US20100069617A1 (en) * 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
EP2326658A4 (fr) * 2008-09-12 2013-04-10 Ge Healthcare Bio Sciences Ab Séparation protéine-agrégat améliorée avec des échangeurs d'anions multimodaux en présence de zwitterions exclus de la protéine
AU2009347206C1 (en) 2008-10-20 2016-12-08 Abbvie Inc. Isolation and purification of antibodies using Protein A affinity chromatography
CA2738499A1 (fr) 2008-10-20 2010-04-29 Abbott Laboratories Inactivation virale pendant la purification d'anticorps
CN104740631B (zh) 2008-10-29 2019-04-16 阿布林克斯公司 单域抗原结合性分子的制剂
EP2346900A1 (fr) 2008-10-29 2011-07-27 Wyeth LLC Procédés de purification de molécules de liaison d'antigène monodomaines
JP2012513425A (ja) * 2008-12-22 2012-06-14 エフ．ホフマン−ラ ロシュ アーゲー 免疫グロブリンの精製
PT3272764T (pt) * 2009-12-18 2024-04-24 Novartis Ag Método para cromatografia de afinidade
US8951807B2 (en) 2010-01-15 2015-02-10 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
MY161534A (en) * 2010-05-25 2017-04-28 Genentech Inc Methods of purifying polypeptides
EP2583973B1 (fr) * 2010-06-21 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Procédé de purification d'une protéine utilisant un acide aminé
GB201012603D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
EP2598515B1 (fr) * 2010-07-30 2016-09-21 Pfizer Inc Purification de protéines en tandem
US8895707B2 (en) 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
AU2011329053A1 (en) 2010-11-15 2013-06-06 Biogen Inc. Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
EP2670704B1 (fr) 2011-02-02 2018-12-12 Bio-Rad Laboratories, Inc. Neutralisation d'une surface à base d'apatite par le biais de solutions alcalines
EP2702077A2 (fr) 2011-04-27 2014-03-05 AbbVie Inc. Procédé de contrôle du profil de galactosylation de protéines exprimées de manière recombinante
CA2842559A1 (fr) 2011-07-20 2013-01-24 Zepteon, Incorporated Procedes de separation de polypeptide
DK2773438T4 (da) 2011-11-02 2022-01-03 Hoffmann La Roche Overladnings- og elueringskromatografi
SG10201701224UA (en) 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (fr) 2012-04-20 2013-10-24 Abbvie Inc. Procédés de modulation de la distribution de variant de lysine c-terminal
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) * 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9815695B2 (en) 2012-05-30 2017-11-14 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
EP2855504B1 (fr) * 2012-05-31 2018-10-24 Agency For Science, Technology And Research Purification chromatographique de préparations d'immunoglobuline g comportant des particules présentant des fonctionnalités multimodales
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014092636A1 (fr) 2012-12-14 2014-06-19 Ge Healthcare Bio-Sciences Ab Procédé de nettoyage de colonnes de chromatographie à lit garni
CA2905010A1 (fr) 2013-03-12 2014-09-18 Abbvie Inc. Anticorps humains qui se lient au tnf-alpha et leurs procedes de preparation
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2014159579A1 (fr) 2013-03-14 2014-10-02 Abbvie Inc. Anticorps anti-tnfα ayant mutés et leurs procédés d'utilisation
SI2969099T2 (sl) * 2013-03-14 2022-04-29 Amgen Inc. Odstranjevanje izluženega afinitetnega purifikacijskega liganda
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (fr) 2013-03-14 2014-09-25 Abbvie Inc. Procédés pour la modulation des profils de glycosylation de protéines de traitements à base de protéines recombinantes au moyen de monosaccharides et d'oligosaccharides
JP6472786B2 (ja) 2013-03-15 2019-02-20 アルダー・バイオファーマシューティカルズ・インコーポレーテッド 抗体の精製及び純度のモニタリング
TWI596107B (zh) * 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
BR112016004437A2 (pt) 2013-09-13 2017-10-17 Genentech Inc métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit
SG10201802525QA (en) 2013-09-13 2018-04-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
EP3052640A2 (fr) 2013-10-04 2016-08-10 AbbVie Inc. Utilisation d'ions métaux pour la modulation des profils de glycosylation de protéines recombinantes
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (fr) 2013-11-15 2015-05-21 Abbvie, Inc. Compositions de protéines de liaison génétiquement glycomodifiées
EP3079808B1 (fr) 2013-12-12 2020-05-27 EMD Millipore Corporation Procédé de séparation de protéines monomériques des aggregats de proteins au moyen d'une membrane comprenant un copolymère d'acrylamide de benzyle et d'acrylamide
WO2015200278A1 (fr) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Restauration in-situ d'apatite
CN105392569B (zh) 2014-06-23 2019-08-20 生物辐射实验室股份有限公司 磷灰石预处理
US10688412B2 (en) 2016-07-25 2020-06-23 Cehpalon, Inc. Affinity chromatography wash buffer
EP3769083A1 (fr) 2018-03-21 2021-01-27 Waters Technologies Corporation Préparation d'échantillon à base d'affinité élevée sans anticorps, sorbants, dispositifs et méthodes
WO2019224660A1 (fr) * 2018-05-24 2019-11-28 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 Méthode de production d'adsorbant
WO2020023566A1 (fr) * 2018-07-25 2020-01-30 Merck Sharp & Dohme Corp. Procédés de séparation de lipases de cellules hôtes à partir d'une protéine de production dans des procédés chromatographiques
WO2020172658A1 (fr) 2019-02-24 2020-08-27 Bristol-Myers Squibb Company Procédés d'isolement d'une protéine
US20220387906A1 (en) 2019-03-21 2022-12-08 Codiak Biosciences, Inc. Process for preparing extracellular vesicles
WO2021154908A1 (fr) * 2020-01-29 2021-08-05 Merck Sharp & Dohme Corp. Procédés de séparation de lipases de cellules hôtes d'une production d'anticorps anti-lag3
WO2022066928A2 (fr) 2020-09-23 2022-03-31 Codiak Biosciences, Inc. Procédé de préparation de vésicules extracellulaires
US20230366794A1 (en) 2020-09-23 2023-11-16 Codiak Biosciences, Inc. Process for preparing extracellular vesicles
CA3229079A1 (fr) 2021-08-23 2023-03-02 Genentech, Inc. Processus de purification par chromatographie par echange de cations en mode ecoulement pour conjugues anticorps-medicament
WO2024145232A1 (fr) * 2022-12-30 2024-07-04 Eli Lilly And Company Procédés de purification de dulaglutide à l'aide d'une chromatographie d'interaction hydrophobe

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029583A (en) * 1975-02-28 1977-06-14 Purdue Research Foundation Chromatographic supports and methods and apparatus for preparing the same
JPS63126826A (ja) * 1986-11-14 1988-05-30 Asahi Chem Ind Co Ltd プラスミノ−ゲン活性化因子誘導物質
US5451662A (en) 1987-10-23 1995-09-19 Schering Corporation Method of purifying protein
WO1989003840A1 (fr) * 1987-10-23 1989-05-05 Schering Corporation Procede de purification de proteines
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
EP0365858B1 (fr) 1988-10-26 1994-11-30 American Cyanamid Company Procédé pour réduire le contenu agrégat de matériaux semblables à l'hormone de croissance
GB9022547D0 (en) 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin
US5264555A (en) 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.
CA2106612C (fr) 1993-09-21 2001-02-06 Diana Pliura Processus de chromatographie a deplacement
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
JPH08511280A (ja) * 1994-04-01 1996-11-26 ユニシン・テクノロジーズ・インコーポレーテッド 合成親和性リガンドを用いた免疫グロブリンの精製のための高塩濃度結合バッファー
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
RU2094077C1 (ru) * 1996-07-23 1997-10-27 Акционерное общество закрытого типа "Фосфосорб" Хроматографический способ выделения альфа-фетопротеина
TW505655B (en) 1997-10-14 2002-10-11 Tanox Inc Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography
US6504013B1 (en) 2000-02-01 2003-01-07 Idexx Laboratories, Inc. Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
WO2000015260A1 (fr) 1998-09-16 2000-03-23 Tanox, Inc. Therapie genique anti-ige
AU777203B2 (en) * 1998-12-30 2004-10-07 Hans Olof Johansson Separation method utilizing liquid-liquid partition
MXPA04006053A (es) 2001-12-21 2005-03-31 Immunex Corp Metodos para purificacion de proteina.
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
AU2004215653B2 (en) 2003-02-28 2011-03-17 Lonza Biologics Plc. Antibody purification by protein A and ion exchange chromatography
JP4496168B2 (ja) * 2003-07-28 2010-07-07 株式会社リバース・プロテオミクス研究所 非特異的物質の除去方法
DE602004026343D1 (de) 2003-10-24 2010-05-12 Amgen Inc Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
PT1678208E (pt) * 2003-10-27 2013-07-10 Wyeth Llc Remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatite
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling

Also Published As

Publication number Publication date
IL185687A (en) 2015-05-31
US20070060741A1 (en) 2007-03-15
CN104610422A (zh) 2015-05-13
SI1869065T1 (sl) 2020-08-31
US20120138537A1 (en) 2012-06-07
CR9377A (es) 2008-02-21
NO20074443L (no) 2007-09-27
WO2006099308A3 (fr) 2007-10-25
DK1869065T3 (da) 2020-06-08
IL185687A0 (en) 2008-01-06
CA2601062A1 (fr) 2006-09-21
MX2007011129A (es) 2007-11-06
KR20070121667A (ko) 2007-12-27
BRPI0608584A2 (pt) 2010-01-19
JP2008533473A (ja) 2008-08-21
US20070054390A1 (en) 2007-03-08
ES2797480T3 (es) 2020-12-02
EP1869065A4 (fr) 2012-07-04
WO2006099308A2 (fr) 2006-09-21
JP5199063B2 (ja) 2013-05-15
KR20130128020A (ko) 2013-11-25
CN101175765A (zh) 2008-05-07
RU2007132851A (ru) 2009-04-20
AU2006223180A1 (en) 2006-09-21
HUE049797T2 (hu) 2020-10-28
US9144755B2 (en) 2015-09-29
EP1869065B1 (fr) 2020-05-06
KR101660575B1 (ko) 2016-09-27
BRPI0608584B8 (pt) 2021-05-25
BRPI0608584B1 (pt) 2018-02-06
CA2601062C (fr) 2016-08-02
US8067182B2 (en) 2011-11-29
KR101482791B1 (ko) 2015-01-21
EP1869065A2 (fr) 2007-12-26
PL1869065T3 (pl) 2020-09-21
RU2457214C2 (ru) 2012-07-27
AU2006223180B2 (en) 2011-11-24
PT1869065T (pt) 2020-06-18

Similar Documents

Publication Publication Date Title
HK1210476A1 (en) A method of weak partitioning chromatography
ZA200805297B (en) Method of using ß-hydroxy-ß-methylbutyrate
EP1954667A4 (fr) Procedes de separation d amino-indanes propargyles
EP1933309A4 (fr) Procédé de recherche
SG123650A1 (en) Yield analysis method
EP1951394A4 (fr) Procede chromatographique utilisant des ligands de l'heparine semi-synthetiques
GB0400270D0 (en) A method of authorisation
GB0511639D0 (en) Prediction method
GB0509898D0 (en) Analysis method
GB2421949B (en) Method of analyzing a protein
IL208214A0 (en) Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
GB0418529D0 (en) Method for analysing
EP1846854A4 (fr) Procede d'analyse d'un produit
GB0522644D0 (en) New method for antagonisation of anticoagulants
EP1892301A4 (fr) Procédé pour l'évaluation d'un composé en utilisant rsk1
GB0501725D0 (en) A method of analysis
GB0511461D0 (en) A method of analysis
IL185801A0 (en) Hydrocodone polymorphs
ZA200609731B (en) A method of construction
GB0414809D0 (en) Analytical method
GB0500240D0 (en) New analytical method
GB0510145D0 (en) Method of analysis
GB0511185D0 (en) Method of analysis
GB0502164D0 (en) A method of providing a flanged component
GB0512448D0 (en) Improved seismic method